Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Welsh

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|November 4, 2021
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung CancerLirong Wu, Jun Zhu, Nils-Petter Rudqvist, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 9, 2013
Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancerJames Welsh, Arya Amini, Katherine Ciura, et al.
Age and Ageing|November 13, 2016
New horizons: the management of hypertension in people with dementiaJennifer Kirsty Harrison, Veronika Van Der Wardt, Simon Paul Conroy, et al.
Cancer|April 2, 2011
Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapyAkihiro Suzuki, Lianchun Xiao, Yuki Hayashi, et al.
Current Oncology Reports|March 3, 2011
Update: modern approaches to the treatment of localized esophageal cancerJames Welsh, Arya Amini, Anna Likhacheva, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric studyJames Welsh, Daniel Gomez, Matthew B Palmer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2018
Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical CancerStephanie Dorta-Estremera, Lauren E Colbert, Sita S Nookala, et al.
Communications Medicine|February 28, 2023
MRI-based deep learning can discriminate between temporal lobe epilepsy, Alzheimer's disease, and healthy controlsAllen J Chang, Rebecca Roth, Eleni Bougioukli, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2011
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial marginsJohn A Harvin, Guy Lahat, Arlene M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal EffectsYun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|November 4, 2021
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung CancerLirong Wu, Jun Zhu, Nils-Petter Rudqvist, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 9, 2013
Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancerJames Welsh, Arya Amini, Katherine Ciura, et al.
Age and Ageing|November 13, 2016
New horizons: the management of hypertension in people with dementiaJennifer Kirsty Harrison, Veronika Van Der Wardt, Simon Paul Conroy, et al.
Cancer|April 2, 2011
Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapyAkihiro Suzuki, Lianchun Xiao, Yuki Hayashi, et al.
Current Oncology Reports|March 3, 2011
Update: modern approaches to the treatment of localized esophageal cancerJames Welsh, Arya Amini, Anna Likhacheva, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric studyJames Welsh, Daniel Gomez, Matthew B Palmer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2018
Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical CancerStephanie Dorta-Estremera, Lauren E Colbert, Sita S Nookala, et al.
Communications Medicine|February 28, 2023
MRI-based deep learning can discriminate between temporal lobe epilepsy, Alzheimer's disease, and healthy controlsAllen J Chang, Rebecca Roth, Eleni Bougioukli, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2011
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial marginsJohn A Harvin, Guy Lahat, Arlene M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal EffectsYun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Pageof 11